Figures
- FIGURE 1
Incidence of bronchiectasis in the UK from 2004 to 2013 stratified by age in a) men and b) women.
- FIGURE 2
Prevalence of bronchiectasis in the UK from 2004 to 2013 stratified by age in a) men and b) women.
Tables
- TABLE 1
Incidence of bronchiectasis in 2004 and 2013 stratified by sex and age group
Age years Men Women Overall 2004 2013 2004 2013 2004 2013 18–29 2.44 (0.696–8.56) 1.48 (0.296–7.41) 1.54 (0.317–7.47) 1.55 (0.321–7.482) 2.01 (0.51–8.01) 1.52 (0.31–7.45) 30–39 3.08 (1.01–9.41) 4.14 (1.58–10.85) 3.18 (1.06–9.55) 5.36 (2.30–12.50) 3.13 (1.03–9.47) 4.75 (1.93–11.68) 40–49 7.74 (3.29–15.66) 9.28 (4.88–17.66) 8.95 (4.65–17.23) 13.63 (8.02–23.18) 8.34 (4.23–16.44) 11.44 (6.41–20.42) 50–59 19.91 (12.83–30.89) 26.36 (18.00–38.61) 29.51 (20.57–42.33) 35.96 (25.94–49.86) 24.66 (16.62–36.59) 31.13 (21.91–44.24) 60–69 49.68 (37.62–65.60) 58.06 (44.90–75.09) 60.55 (47.07–77.89) 86.07 (69.69–106.3) 55.17 (42.38–71.82) 72.31 (57.43–91.05) 70–79 73.82 (58.77–92.73) 126.66 (106.43–150.74) 66.32 (52.14–84.36) 124.94 (104.86–148.87) 69.72 (55.14–88.16) 125.74 (105.59–149.74) ≥80 77.68 (62.20–97.02) 117.47 (98.05–140.74) 41.57 (30.68–56.34) 97.85 (80.27–119.28) 54.02 (41.38–70.52) 105.38 (87.08–127.54) Data are presented as incidence rate (95% CI), per 100 000 person-years.
- TABLE 2
Prevalence of bronchiectasis in 2004 and 2013 stratified by sex and age group
Age years Men Women Overall 2004 2013 2004 2013 2004 2013 18–29 28.8 (20.2–33.3) 43.3 (32.2–58.3) 29.7 (20.8–42.5) 43.6 (32.4–58.6) 29.3 (20.4–41.9) 43.4 (32.3–58.4) 30–39 38.7 (28.3–53.0) 58.2 (45.0–75.2) 53.4 (40.8–69.8) 79.3 (63.7–98.8) 46.0 (34.5–61.4) 68.8 (54.3–87.0) 40–49 85.2 (68.9–105.3) 97.4 (79.9–118.7) 110.7 (91.9–133.3) 142.1 (120.6–167.4) 98.0 (80.4–119.4) 119.8 (100.2–143.2) 50–59 286.9 (255.6–322.0) 224.0 (196.5–255.3) 391.1 (354.3–431.7) 285.9 (254.6–321.0) 339.0 (304.8–377.0) 254.9 (225.5–288.2) 60–69 477.4 (436.5–522.1) 629.3 (582.1–680.2) 638.4 (590.9–689.7) 866.0 (810.4–925.3) 557.9 (513.6–606.0) 747.7 (696.1–803.0) 70–79 608.0 (561.7–658.1) 1109.0 (1045.9–1175.8) 698.1 (648.4–751.6) 1370.3 (1300.1–1444.2) 653.0 (605.0–704.9) 1239.7 (1172.9–1310.1) ≥80 583.0 (537.7–632.1) 1236.9 (1170.2–1307.3) 532.3 (489.1–579.3) 1175.6 (1110.6–1244.3) 557.7 (513.4–605.8) 1206.3 (1140.5–1275.8) Data are presented as prevalence (95% CI), per 100 000.
- TABLE 3
Baseline characteristics of the bronchiectasis study population
Study population 18 793 Age at diagnosis years 61.8 (47.5–72.2) Length of time in study years 7.2 (3.6–7.9) Sex Male 7798 (41.5) Female 10 995 (58.5) Smoking habit# Never-smoker/not recorded 6003 (31.9) Ex-smoker 7118 (37.9) Current smoker 5672 (30.2) Index of multiple deprivation 1 (least deprived) 3082 (16.4) 2 3013 (16.0) 3 2243 (11.9) 4 1935 (10.3) 5 (most deprived) 1728 (9.2) Unavailable 6792 (36.1) Data are presented as n, median (interquartile range) or n (%). #: ever, closest to diagnosis date.
- TABLE 4
Coexisting diagnoses associated with bronchiectasis#
Study population 18 793 Asthma 7988 (42.5) Chronic obstructive pulmonary disease 6774 (36.1) HIV 1300 (6.9) Rheumatoid arthritis 1163 (6.2) Other connective tissue diseases 969 (5.2) Inflammatory bowel disease 527 (2.8) Bone marrow transplant 20 (0.11) Hypogammaglobulinaemia 172 (0.9) Allergic bronchopulmonary aspergillosis 339 (1.8) None of these comorbidities 6422 (34.2) Data are presented as n or n (%). #: some patients had multiple comorbidities.
- TABLE 5
Crude mortality rates by age group in 2010
Age years Men Women General population Bronchiectasis cohort General population Bronchiectasis cohort 18–49 1.3 (1.3–1.4) 13.1 (3.4–22.8) 0.8 (0.7–0.8) 6.4 (0.8–12.0) 50–59 5.1 (5.0–5.2) 10.0 (2.6–17.3) 3.4 (3.4–3.5) 7.8 (2.4–13.2) 60–69 12.5 (12.3–12.6) 29.5 (20.6–38.4) 7.9 (7.8–8.0) 16.0 (10.6–21.5) 70–79 33.77 (33.4–33.9) 58.6 (46.4–70.7) 22.8 (22.6–23.0) 43.9 (34.9–52.8) ≥80 111.8 (111.1–112.5) 144.6 (115.4–173.9) 98.9 (98.4–99.4) 160.1 (136.1–184.1) Data are presented as mortality rate (95% CI), per 1000 population. Rates have been calculated using a mid-year population estimate for 2010.
Disclosures
Supplementary material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
- Supplementary material - Read codes for bronchiectasis
